Table 1.
Substances | [3H]E2 Binding remaining (%) |
[3H]R1881 Binding remaining (%) |
||
---|---|---|---|---|
cERa | nERa | cARa | nARa | |
E1 | 50 | 25 | – | – |
E2 | 25 | 26 | 64 | 68 |
E3 | 58 | 45 | – | – |
DES | 40 | 30 | 98 | 97 |
R1881 | 100 | 94 | 19 | 27 |
Cortisone | 100 | 93 | 75 | – |
Progesterone | 100 | – | 95 | – |
Triamcinolone acetonide | – | – | 48 | 100 |
Cyproterone acetate | – | – | 56 | 74 |
cAR, cytosolic androgen receptor; cER, cytosolic estrogen receptor; DES, diethylstilbesterol; E1, estrogen; E2, estradiol; E3, estriol; nAR, nuclear androgen receptor; nER. nuclear estrogen receptor.
Cytosol and nuclear fractions were prepared and incubated with 3H-steroid and either no competitor (100%) value or a 100-fold excess of the substances listed, as described in Materials and Methods. No triamcinolone acetonide was included in the assay except in its use as a potential competitor.